ClinConnect ClinConnect Logo
Search / Trial NCT05981482

Visual Perception Difficulties After Stroke

Launched by DURHAM UNIVERSITY · Jul 31, 2023

Trial Information

Current as of August 20, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial, titled "Visual Perception Difficulties After Stroke," is studying how well a new screening tool called the Oxford Visual Perception Screening (OxVPS) can detect visual perception problems in people who have survived a stroke. Visual perception refers to how the brain interprets what the eyes see, and difficulties in this area can make daily activities challenging for stroke survivors. The trial aims to see how accurately the OxVPS identifies these issues compared to the standard testing method currently used.

To participate in this study, individuals must have been diagnosed with a stroke within the last six weeks, which could be either an ischemic stroke (caused by a blockage in blood flow) or an intracerebral hemorrhage (bleeding in the brain). Eligible participants will complete both the OxVPS and the standard screening tool during the trial. The study is currently looking for participants aged 65 to 74, and it is open to everyone regardless of gender. However, those who cannot understand English, have trouble following simple instructions, or are unable to concentrate for about 15 minutes will not be able to participate. This research is important because it could help improve the way we identify and support stroke survivors facing visual perception challenges.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients with a clinical diagnosis of stroke (ischemic stroke and/or intracerebral haemorrhage).
  • Within 6 weeks of confirmed stroke.
  • Exclusion Criteria:
  • Insufficient understanding of English
  • Clinical concerns that patient is unable follow simple instructions.
  • Clinical concerns that patient is unable to concentrate for 15 minutes.
  • No capacity to provide informed consent.

About Durham University

Durham University, a prestigious institution located in the United Kingdom, is renowned for its commitment to advancing research and innovation across various disciplines, including health sciences. As a clinical trial sponsor, Durham University leverages its rich academic resources and interdisciplinary expertise to design, conduct, and oversee clinical studies aimed at improving patient outcomes and informing healthcare practices. The university's dedication to ethical research and collaboration ensures rigorous adherence to regulatory standards, fostering an environment that promotes scientific integrity and impactful findings. Through its clinical trials, Durham University aims to contribute valuable insights that enhance the understanding and treatment of complex health issues.

Locations

Gateshead, , United Kingdom

Abingdon, , United Kingdom

Bishop Auckland, , United Kingdom

Patients applied

0 patients applied

Trial Officials

Kathleen Vancleef, PhD

Principal Investigator

Durham University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported